McKesson Corporation recently reported its fiscal 2024 full-year results, which missed the mark despite demonstrating strong growth and strategic expansions. The report included mixed results amidst revenue growth and an adjusted EPS. McKesson's stock outperformed competitors on several trading days, attracting substantial institutional ownership. The company is expected to continue delivering strong growth with its positive 2025 fiscal outlook, and its shares are considered a strong value stock. McKesson Corporation aims to strengthen its status through presentations at various healthcare conferences.
Mckesson Corporation MCK News Analytics from Wed, 11 Oct 2023 07:00:00 GMT to Thu, 09 May 2024 10:06:55 GMT -
Rating 5
- Innovation 3
- Information 7
- Rumor -6
